Influx Healthtech IPO Booked Over 200 Times; GMP Up 22%; Check Allotment Details And More
The latest grey market premium (GMP) for the Influx Healthtech IPO was Rs 22 on June 20.
The initial public offering of Influx Healthtech Ltd., which launched its initial public offering (IPO) on Wednesday, closed for subscription today.
The SME IPO was booked over 200 times on Friday. The demand for the issue was led by Non-institutional investors who bid over 480 times the alloted shares. Retail investors bid for 23,87,97,600 shares against the 8,70,000 on offer, subscribing over 117 times. Qualified Institutional investors subscribed their quota of shares over 137 times.
As subscription for the SME issue concluded on its final day, here's all you need to know about the Influx Healthtech IPO, including the latest grey market premium, allotment details, listing date and more.
Influx Healthtech IPO: All You Need To Know
The Influx Healthtech IPO is a book-building issue worth Rs 55.63 crore. It comprises a fresh issue of 46.94 lakh shares, worth Rs 45.07 crore, and an offer-for-sale of 11 lakh shares, amounting to Rs 10.56 crore.
The price band for the IPO was fixed between Rs 91 and Rs 96 per share.
Retail investors could invest in the IPO by bidding for a single lot size of 1200 shares, requiring an investment of Rs 1,15,200.
Of the 43,64,400 shares on offer
11,59,200 (26.56%) are allocated to Qualified Institutional investors
8,70,000 (19.93%) are allocated to Non-Institutional investors
20,29,200 (46.49%) are allocated to Retail investors
Rarever Financial Advisors Pvt. is the book-running lead manager of the Influx Healthtech IPO. Maashitla Securities Pvt. is the registrar and RK Stock Holding Pvt. is the market maker for the issue.
Influx Healthtech IPO Day Three Subscription Status
The Influx Healthtech IPO was subscribed 201.35 times on Friday.
Qualified Institutional Buyers: 137.87 times
Non-Institutional Investors: 481.10 times
Retail Investors: 117.68 times
Influx Healthtech IPO GMP Today
According to InvestorGain, the grey market premium (GMP) for the Influx Healthtech IPO was Rs 22 as of 5:35 p.m. on June 20. The latest GMP indicates it will list at Rs 118 per share, at a premium of 22.92% apiece on the upper end of the price band.
According to the latest GMP trends, the grey market premium for the Influx Healthtech IPO was as high as Rs 45 when the issue opened for subscription on June 18.
Note: GMP does not represent official data and is based on speculation.
Influx Healthtech IPO Allotment And Listing Date
The allotment for the Influx Healthtech IPO will be finalised on June 23. Successful bidders will receive the shares in their Demat accounts on June 24. Refunds for non-allottees will also be processed on the same day.
Influx Healthtech's IPO listing is scheduled for June 25. Shares of Influx Healthtech Ltd. will be listed on the NSE SME platform.
Where To Check Influx Healthtech IPO Allotment Status
One the company finalises the share allotment status, bidders can verify their Influx Healthtech IPO Allotment Status on the websites of NSE and Maashitla Securities.
NSE: https://www.nseindia.com/invest/check-trades-bids-verify-ipo-bids
Maashitla: https://maashitla.com/allotment-status/public-issues
Influx Healthtech: Business, Financials and Use of IPO Proceeds
The company is a manufacturer of healthcare products. Its portfolio includes nutraceuticals, cosmetics, Ayurvedic and veterinary feed supplements.
The company will use proceeds from the IPO to set up manufacturing facilities, buy machinery and for general corporate purposes.
The company’s profit after tax (PAT) rose 20.1% year-on-year (YoY) to Rs 13.37 crore in FY25 from Rs 11.13 crore in FY24. Revenue from operations increased 4.9% YoY to Rs 104.85 crore in FY25 from Rs 99.96 crore in FY24.
Disclaimer: Investments in initial public offerings are subject to market risks. Please consult with financial advisors and read the red herring prospectus thoroughly before placing bids.
